AMRC
Ameresco, Inc.
AMRC has lower modeled downside risk, despite its lower overall score.
RKLB
Rocket Lab USA, Inc.
RKLB has the edge over AMRC overall, supported by stronger fundamentals and stronger valuation.
AMRC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Weak | |
| Weak |
AMRC's revenue and profitability are currently stable, but its cash flow and balance sheet are weak.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
AMRC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 14x | $25.89 | — |
| Cheap | 23x | $17.56 | -32% |
| Fair | 32x | $24.21 | -6.5% |
| Current | 34x | $25.89 | — |
| Expensive | 46x | $34.96 | +35% |
Historical ranges are pointers, not guarantees.
AMRC's PE is in its fair range at 34x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its cheap range.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
AMRC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for AMRC, with profitability improving.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
AMRC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.85 | +144% |
| Q3 2026 | $0.76 | -37% |
| Q2 2026 | $0.52 | -56% |
| Q1 2026 | $0.58 | -44% |
| Q4 2025 | $0.83 | -22% |
| Q3 2025 | $1.20 | +21% |
| Q2 2025 | $1.18 | +11% |
| Q1 2025 | $1.03 | -5.5% |
| Q4 2024 | $1.07 | -8.5% |
AMRC has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
AMRC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $580.3M | +10% |
| Q2 2026 | $515.5M | +9.1% |
| Q1 2026 | $401.5M | +14% |
| Q4 2025 | $581M | +9.1% |
| Q3 2025 | $526M | +5% |
| Q2 2025 | $472.3M | +7.8% |
| Q1 2025 | $352.8M | +18% |
| Q4 2024 | $532.7M | +21% |
AMRC's revenue has grown year over year for 12 quarters in a row: $580M last quarter, up 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +2.5 points |
| Q2 2026 | 8.6% | +2.7 points |
| Q1 2026 | 2.5% | -1.3 points |
| Q4 2025 | 8% | -0.4 points |
| Q3 2025 | 8.1% | +1 points |
| Q2 2025 | 5.9% | +1.1 points |
| Q1 2025 | 3.9% | +1.2 points |
| Q4 2024 | 8.4% | +0.7 points |
AMRC has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over AMRC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
AMRC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$9.5M | -153% |
| Q2 2026 | -$108.1M | -$81.1M |
| Q1 2026 | $34.9M | +$63.6M |
| Q4 2025 | -$98.7M | -676% |
| Q3 2025 | $18.1M | -25% |
| Q2 2025 | -$27M | -152% |
| Q1 2025 | -$28.7M | -245% |
| Q4 2024 | $17.1M | +$47.8M |
AMRC has burned cash in most quarters: −$181M over the past year, against −$21M the year before.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has the edge over AMRC on cash flow, with more consistent year-over-year improvement.
AMRC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.9x | High |
| Q2 2026 | 7.2x | High |
| Q1 2026 | 8.1x | High |
| Q4 2025 | 8.1x | High |
| Q3 2025 | 7.7x | High |
| Q2 2025 | 7.9x | High |
| Q1 2025 | 7.9x | High |
| Q4 2024 | 7.7x | High |
AMRC's net debt is about 6.9 years of its operating earnings (EBITDA), down from 7.7 years a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AMRC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.2 | Neutral |
| Stochastic | 37.7 | Neutral |
AMRC's weekly RSI is 54 (neutral) and its Stochastic is 38 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
AMRC PE vs Industrials Sector
| Metric | AMRC | Sector median | Relative |
|---|---|---|---|
| PE | 34x | 24x | 42% above |
| PE % | 57 | 58 | 1 pt below |
AMRC is trading at 34x earnings, a 42% premium to the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
AMRC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.3 | 22% above |
| 20 week MA | $22.7 | 14% above |
| 50 week MA | $26.9 | 3.8% below |
| 100 week MA | $24.3 | 6.5% above |
| 200 week MA | $29.9 | 13% below |
AMRC's trend is mixed: it's above three of its five weekly moving averages, and 13% below its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
AMRC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.5 | $49.4 | +183% |
| 2021 | $49.4 | $77.9 | +58% |
| 2022 | $77.9 | $56.3 | -28% |
| 2023 | $56.3 | $31.7 | -44% |
| 2024 | $31.7 | $23.2 | -27% |
| 2025 | $23.2 | $30.2 | +30% |
| 2026 YTD | $30.2 | $25.9 | -14% |
AMRC's yearly returns have swung widely, from +183% in 2020 to −44% in 2023. It's down 14% so far in 2026.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over AMRC on returns for 2026, with the stronger performance.